1 |
Kim HL, Seo JB, Chung WY, Kim SH, Kim MA, Zo JH. The incidence and predictors of overall adverse effects caused by low dose amiodarone in real-world clinical practice. Korean J Intern Med 2014;29:588-596.
DOI
ScienceOn
|
2 |
Goldschlager N, Epstein AE, Naccarelli GV, et al. A practical guide for clinicians who treat patients with amiodarone: 2007. Heart Rhythm 2007;4:1250-1259.
DOI
ScienceOn
|
3 |
Vorperian VR, Havighurst TC, Miller S, January CT. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 1997;30:791-798.
DOI
ScienceOn
|
4 |
Mantyjarvi M, Tuppurainen K, Ikaheimo K. Ocular side effects of amiodarone. Surv Ophthalmol 1998;42:360-366.
DOI
ScienceOn
|
5 |
Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997;350:1417-1424.
DOI
ScienceOn
|
6 |
Dusman RE, Stanton MS, Miles WM, et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation 1990;82:51-59.
DOI
ScienceOn
|
7 |
Basaria S, Cooper DS. Amiodarone and the thyroid. Am J Med 2005;118:706-714.
DOI
ScienceOn
|
8 |
Cho YK, Kim YN, Han SW, et al. Clinical reviews about overall incidence of adverse effects in amiodarone treatment. Keimyung Med J 2007;26:87-95.
|
9 |
Hohnloser SH, Crijns HJ, van Eickels M, et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009;360:668-678.
DOI
ScienceOn
|
10 |
Le Heuzey JY, De Ferrari GM, Radzik D, Santini M, Zhu J, Davy JM. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. J Cardiovasc Electrophysiol 2010;21:597-605.
DOI
ScienceOn
|